Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized Sham-Controlled Trial With Allocation Concealment and Blinded Patients and Assessors, Investigating Hyperbaric Oxygen as a Radiation Sensitizer for Locally Advanced Squamous Cell Carcinoma of the Oropharynx and Larynx

NCT03843671 is registered in ClinicalTrials.gov with National Baromedical Services as lead sponsor.

NCT NCT03843671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03843671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized Sham-Controlled Trial With Allocation Concealment and Blinded Patients and Assessors, Investigating Hyperbaric Oxygen as a Radiation Sensitizer for Locally Advanced Squamous Cell Carcinoma of the Oropharynx and Larynx
Lead sponsor
National Baromedical Services
Phase
Phase 2
Overall status
Unknown status
Start date
July 1, 2019
Completion date
December 31, 2024
Enrollment
400 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the head and neck